Listed by the USPTO as WORSHAM, JESSICA N
Tech Center 1600 • Art Units: 1615
This examiner grants 56% of resolved cases
WORSHAM, JESSICA N is assigned to tech center 1600 and art unit 1615. The record includes 757 resolved cases, with an allowance rate of 56.5% and a median time to allowance of 1081 days. The volume supports using the outcome as a meaningful historical reference, while the allowance rate indicates that prosecution results are mixed.
The interview lift is 56.4%, making interviews a prominent strategic option in this record. Counsel may prepare focused interview agendas alongside written responses, particularly where claim amendments or technical distinctions require clarification. The listed companies are Harmony Foods LLC, Massachusetts Institute of Technology, and P Tech LLC. The listed firms are BIRCH STEWART KOLASCH & BIRCH, LLP, SUGHRUE MION, PLLC, and BakerHostetler.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19647159 | PALATABLE CHEWABLE COMPOSITIONS WITH IMPROVED TASTE MASKING | Non-Final OA | Harmony Foods LLC |
| 19443532 | PALATABLE CHEWABLE COMPOSITIONS WITH IMPROVED TASTE MASKING | Non-Final OA | Harmony Foods LLC |
| 18714142 | POLY(BETA-AMINO ESTER) MICROPARTICLES FOR MICRONUTRIENT FORTIFICATION | Non-Final OA | Massachusetts Institute of Technology |
| 19397956 | TREATMENT OF BLOOD LOSS AT TISSUE WOUND | Final Rejection | P Tech, LLC |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | Non-Final OA | Washington University |
| 18291525 | BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY | Non-Final OA | Regents of the University of Minnesota |
| 18684728 | DIRECT TABLETING AUXILIARY COMPOSITION | Non-Final OA | BASF SE |
| 18560900 | SEED TREATMENT COMPOSITIONS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18701581 | TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS USING NANO POLYMERS OF HISTONE DEACETYLASE INHIBITORS | Non-Final OA | University of Virginia Patent Foundation |
| 18879145 | DISPERSION AND COSMETIC CONTAINING SAME | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 17926040 | METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE | Non-Final OA | BETH ISRAEL DEACONESS MEDICAL CENTER |
| 18741628 | METHODS OF FORMING STORAGE STABLE MIXTURES | Non-Final OA | DSM IP Assets B.V. |
| 18261762 | METHODS OF SELECTIVELY PROMOTING GASTROINTESTINAL MICROBIAL GROWTH | Final Rejection | DSM IP Assets B.V. |
| 18888697 | IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF | Non-Final OA | Flagship Pioneering Innovations VII, LLC |
| 18034969 | NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT | Final Rejection | Purdue Research Foundation |
| 18005240 | MEDICAL DEVICES HAVING ANTI-MICROBIAL PROPERTIES AND METHODS FOR MAKING THE SAME | Non-Final OA | Hollister Incorporated |
| 18865572 | PLANT DISEASE CONTROL METHOD | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18849372 | Lipid Based Nanoparticles for Targeted Gene Delivery to the Brain | Non-Final OA | National Research Council of Canada |
| 17927168 | METAL-ORGANIC FRAMEWORKS DELIVER SMALL MOLECULES AND BIOMACROMOLECULES FOR CANCER IMMUNOTHERAPY | Non-Final OA | The University of Chicago |
| 18006630 | ADHESIVE, EXTRUDABLE ABOVE-GROUND TERMITE BAIT AND METHODS FOR MANUFACTURING SAME | Non-Final OA | DOW AGROSCIENCES LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy56.5% of resolved applications examined by Jessica N Worsham were allowed (757 resolved cases), compared with 43.8% across Art Unit 1615 over the last five years.
This examiner's interview lift is +56.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jessica N Worsham took 1,081 days on average from filing to allowance.
Jessica N Worsham examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).